AIHW Board AIHW senior staff Annual report Capability statement Collaboration AIHW corporate plan 2016–17 to 2019–20 Customer care charter FOI - freedom of information Indexed list of files Nous review Organisation chart Presentations Privacy of data Public Interest Disclosure Tenders
By category Ageing, disability & carers Families & children Hospitals Housing & homelessness Indigenous Australians Population groups Risk factors, diseases & death Services, workforce & spending
By subject Adoptions Aged care Ageing Alcohol & other drugs Arthritis & musculoskeletal conditions Asthma Australia's health Australia's welfare Burden of disease Cancer Cardiovascular disease Child health, development & wellbeing Child protection Children's services Chronic diseases
Chronic kidney disease Chronic respiratory conditions COPD Deaths Dementia Dental & oral health Diabetes Disability Expenditure Eye health Food & nutrition Health indicators Health performance Homelessness Hospitals Housing assistance Indigenous Australians Injury Life expectancy
Male health Mental health Mothers & babies Overweight & obesity Palliative care services Population health Primary health care Prisoner health Risk factors Rural health Safety & quality of health care Veterans' health Workforce Youth health & wellbeing Youth justice
In other sections Data Publications Contact AIHW
Publications CatalogueOrdering publicationsForthcoming publications Online reports Subscribe to release notices
By subject Adoptions Aged care Ageing Alcohol & other drugs AIHW annual reports Arthritis & musculoskeletal conditions Asthma Australia's health Australia's welfare Burden of disease Cancer Cardiovascular disease Child health, development & wellbeing Child protection Children's services Chronic diseases Chronic kidney disease
Chronic respiratory conditions Corporate publications Data linkage Data standards Deaths Dental & oral health Diabetes Disability Expenditure Eye health Food & nutrition General practice Health indicators Health performance Homelessness Hospitals Housing assistance Indigenous Australians Indigenous housing
Injury Life expectancy Male health Mental health services Mothers & babies Overweight & obesity Palliative care Population health Primary health carePrisoner health Risk factors Rural health Safety & quality of health care Veterans' health Workforce Youth health & wellbeing Youth justice
In other sections Subjects Data Contact AIHW
About AIHW data METeOR—metadata online registry Data by subject AIHW data collections Customised data analysis request Data governance framework Data linking Data standards GovHack Privacy of data Accessing Australian Government health and welfare data
By subjectAboriginal and Torres Strait Islander Health Performance Framework Adoptions Aged care Alcohol and other drugs Alcohol data sources Body weight data sources Cancer Children's headline indicators (CHI) Child protection Data sources for monitoring health conditionsDeaths Diabetes Disability
Expenditure FHBH - Fixing houses for better health General Record of Incidence of Mortality (GRIM) books Height and weight data sources Hospitals Indigenous Australians International collaboration Maternity Information Matrix (MIM) Medical indemnity Mental health Mortality Over Regions and Time (MORT) books National Aged Care Data Clearinghouse
National core maternity indicators (NCMI) National framework for protecting Australia’s children (NFPAC) National indicator catalogue National Youth Information Framework (NYIF) Perinatal data Primary Health Network (PHN) Specialist Homelessness Services (SHS) Tobacco data sources Workforce
In other sections Subjects Publications Contact AIHW
ACFADD AHSAC AIHW Board AIHW Ethics Committee AODTS NMDS WG Cancer CKDMAC CVDMAC HEAC
IGIHM JJ RIG MHISSC NAGATSIHID NCSIMG NDDWG NDIMG NHISSC NIAG NIRAPIMG NMDDNMDS
NMHPSC NOPSAD NPDDC NPHEP NPHIC PCDWG PDWG PHIDG PHIG REDWG Workforce committees
Education worksheets Infographics What's in the pipeline Subscribe to education notices Other educational links
Resources by subject All Latest Ageing Australia's health Australia's welfare Carers
Children & youth Disability Disease Drugs
Health Health prevention Indigenous Australians Injury
In other sections Subjects Data Publications Contact AIHW
Job vacancies How to apply for a position at the AIHW Conditions of employment Benefits of working for the AIHW Temporary employment register Occupational Training Program Contact the People Unit Graduates
AIHW Access magazine Media releases Subscribe to release notices Embargoed access to AIHW material Media contacts
You are here:
This is a snapshot of the latest statistics on allergic rhinitis in Australia. More detailed information can be found in the report Allergic rhinitis ('hay fever') in Australia.
For personal medical advice, see your doctor.
Information in this snapshot was last updated December 2016.
Allergic rhinitis is triggered by an allergic reaction. The symptoms may include a runny or blocked nose and/or sneezing and watery eyes. Allergic rhinitis can occur seasonally (commonly referred to as 'hay fever') or throughout the year. Common triggers include house dust, animal fur, pollens, fungal spores, air pollutants and occupational triggers such as latex, breads and cereals or small animals.
Australians suffered from allergic rhinitis in 2014–15.
That's nearly 4.5 million people.
the age where allergic rhinitis was the most prevalent.
Unlike many health conditions, allergic rhinitis is most common in the middle years of life (15–59 years), rather than in children or older Australians.
had the highest rate of allergic rhinitis in Australia (26%) in 2014–15.
The second highest rate was in Tasmania (23%). The lowest rates were in NT (12%) and Qld (17%).
Source: AIHW analysis of of ABS National Health Survey, 2014–15 (TableBuilder) (Data tables).
There are a range of treatments available for allergic rhinitis, many of which do not require a presciption from a doctor. The main medicines used are intranasal corticosteroids (nasal sprays) and oral antihistamines. For persistent allergic rhinitis and for moderate/severe intermittent allergic rhinitis, guidelines recommend the use of nasal sprays as the first-line therapy. For mild intermittent hay fever, the use of antihistamines is recommended.
Comprehensive data are not available on the use of allergic rhinitis medicines. Data from pharmacy suppliers, however, suggest that spending by pharmacies on these medicines doubled between 2001 and 2010, going from $107.8 million to $226.8 million per year. While not all of these medicines would have been used for allergic rhinitis, treatment of this condition is likely to have accounted for a large proportion of the increase.
Each year between 2006 and 2010, the wholesale supplies of oral antihistamines increased around July and peaked around October–November.
AIHW 2011. Allergic rhinitis ('hay fever') in Australia.